Proton Therapy Trial Among Patients With Stage I NSCLC
Researchers are evaluating whether hypoIGRT is an effective treatment strategy for patients with stage I NSCLC who are not candidates for surgery.
Title: Hypofractionated, Image-Guided Radiation Therapy With Proton Therapy for Stage I Non-Small Cell Lung Cancer1
Principal Investigators: Bradford S Hoppe, MD, MPH, University of Florida Proton Therapy Institute
Description: For this non-randomized study (ClinicalTrials.gov Identifier: NCT00875901), researchers are evaluating whether photon radiation therapy — hypofractionated image guided radiation therapy (hypoIGRT) — is an effective treatment strategy for patients with stage I non-small cell lung cancer (NSCLC) who are not candidates for surgery.
This treatment method is typically completed within 2 to 3 weeks, while conventional radiotherapy requires 7 to 8 weeks of treatment.